Antibody-Mediated Rejection: Challenges and Treatment Options

<p>Yen Tran, PharmD, MBA (<a href='https://twitter.com/Yentranlt'>@YenTranlt</a>) illustrates the consequences of antibody mediated rejection (AMR) on solid organ transplant recipients, develops a management strategy for AMR and outlines approaches to AMR management.</p> <p>For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href='https://twitter.com/MayoPharmRes'>@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href='https://twitter.com/garrett_schramm'>@garrett_schramm</a> on Twitter!</p> <p>You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>